Search results
Mar 21, 2023 · Frank Schlosser, Robert Koch Institute, Berlin 13353, Germany. Institute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt University of Berlin, Berlin 10115, Germany. Matthias an der Heiden, Robert Koch Institute, Berlin 13353, Germany. Ole Wichmann, Robert Koch Institute, Berlin 13353, Germany.
- 10.1093/biomethods/bpad005
- 2023
- Biol Methods Protoc. 2023; 8(1): bpad005.
Mar 21, 2023 · Abstract. In November 2021, the first infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) B.1.1.529 ('Omicron') was reported in Germany, alongside global reports of reduced vaccine efficacy (VE) against infections with this variant. The potential threat posed by its rapid spread in Germany was ...
Jan 6, 2022 · Quick Take Social Media Users claim that Robert Koch Institute (RKI) shows 95.58% of Omicron cases in Germany have occurred in fully vaccinated people. We fact-checked and found the claim to be False. The Claim A social media user claims, “JUST IN – Robert Koch Institute report released today...
Jul 10, 2022 · BACKGROUND In November 2021, the first case of SARS-CoV-2 “variant of concern” (VOC) B.1.1.529 (“Omicron”) was reported in Germany, alongside global reports of reduced vaccine efficacy against infections with this variant. The potential threat posed by the rapid spread of this variant in Germany remained, at the time, elusive. METHODS We developed a variant-dependent population ...
Jan 5, 2022 · "JUST IN - Robert Koch Institute report released today states that 95.58% of the #Omicron cases in Germany are fully vaccinated (28% of those had a "booster"), 4.42% are unvaccinated."
Aug 24, 2022 · To summarize the existing evidence on the effectiveness and the duration of protection conferred by COVID-19 vaccines licensed in the European Union (EU) with respect to the Omicron variant and compare it to the Delta variant, we synthesized the evidence within an ongoing living systematic review (LSR), conducted by the Robert Koch Institute ...
- 10.3389/fimmu.2022.940562
- 2022
- Front Immunol. 2022; 13: 940562.
Mar 13, 2023 · Purpose COViK, a prospective hospital-based multicenter case-control study in Germany, aims to assess the effectiveness of COVID-19 vaccines against severe disease. Here, we report vaccine effectiveness (VE) against COVID-19-caused hospitalization and intensive care treatment during the Omicron wave. Methods We analyzed data from 276 cases with COVID-19 and 494 control patients recruited in 13 ...
